Overview

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The co-primary objectives will be to assess the safety and quality of life under treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Institut Paoli-Calmettes
Collaborator:
Société Francophone d'Onco-Gériatrie
Treatments:
Immune Checkpoint Inhibitors
Immunologic Factors